Profiling Human Papillomavirus Lineage-Specific Capsid Antigenicity With Geographically Diverse Natural Infection Antibodies
Human papillomavirus variants are classified into lineages based on their whole genome sequence, but the impact of lineage variation on the structure or function of encoded proteins is unclear. We used a global panel of lineage-specific natural infection sera to assess antibody-binding specificity for lineage-specific L1L2 antigens, and we used these data to create relational antigenic maps. Merging these data with neutralizing antibody data demonstrated similar spatial geometry and revealed dependency on a limited number of amino residues on the capsid surface. These data inform the degree of lineage specificity within the natural infection humoral immune response to oncogenic human papillomaviruses.
Authors
- Kavita Panwar (ORCID: https://orcid.org/0000-0002-1052-4698)
- Simon Beddows (ORCID: https://orcid.org/0000-0002-6879-6215)
- Lisa Mirabello (ORCID: https://orcid.org/0000-0001-8485-0106)
- Mónica S. Sierra
- Kazutomo Yokoya (ORCID: https://orcid.org/0000-0002-5280-185X)
- Vanessa Tenet
- John Schussler (ORCID: https://orcid.org/0000-0002-8793-0766)
- Gary M. Clifford (ORCID: https://orcid.org/0000-0001-7534-333X)
- John T. Schiller (ORCID: https://orcid.org/0000-0001-7308-950X)
- Rolando Herrero
- Shayane Martins Rodrigues Gomes (ORCID: https://orcid.org/0000-0002-4836-5725)
Institutions
- Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (CR)
- Information Management Services (US)
- National Cancer Institute (US)
- Cancer Genetics (United States) (US)
- Center for Cancer Research (US)
- Associated Management Services (United States) (US)
- Centre international de recherche sur le cancer (FR)
- UK Health Security Agency (GB)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1093/infdis/jiaf502
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline
- Austrian Centre of Industrial Biotechnology
- National Institutes of Health
- National Cancer Institute
- Office of Research on Women's Health